DNA Test Jailed Innocent Man for Murder
By Hannah Barnes,
BBC News
| 08. 31. 2012
Scientists, lawyers and politicians have raised new concerns over the quality of forensic evidence testing - so is the criminal justice system too reliant on lab tests without realising their limitations?
"There was a knock at the door, in the early hours of the morning, saying I was being arrested for murder. I asked, 'what evidence have you got?' and they said they thought it was my DNA.
"I thought 'I'll prove I'm not a suspect' but it didn't pan out that way. DNA has become the magic bullet for the police... they thought it was my DNA, ergo it must be me."
David Butler has every right to be cynical about the use of DNA evidence by the police. He spent eight months in prison, on remand, facing murder charges after his DNA was allegedly found on the victim.
"That was when Alice fell down the hole. Everything went upside down. My whole life changed overnight," he told Radio 4's The Report.
"It was hard. The loneliness was the worst, not speaking to your family. I've led a...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...